Uncovering Denials: OIG Reports Reveal Alarming Trends in Medicaid Managed Care Plans

Published in Government Relations on August 25, 2023

In 2022, the OIG released a report outlining their findings which concluded that Medicare Advantage plans were routinely denying authorizations requests and claims for items that would be covered by traditional Medicare Fee For Service (FFS). On July 17, 2023, the OIG released a similar report which shows something similar may be happening within Medicaid Manage Care plans. The three main things that they concluded from their research was that within Medicaid managed care programs:

  1. A high number and rate of denied prior authorization (PA) requests by some MCOs, some of which very likely should have been approved,
  2. limited oversight of prior authorization denials in most States, and
  3. limited access to external medical reviews and a cumbersome appeal and/or state fair hearing process, which may deter providers and or Medicaid patients from pursuing that option.

While conducting their analysis, the OIG looked at authorization and claims data from seven parent companies, namely Molina, CareSource, UHC, Centene, Anthem/Elevance, Aetna, and AmeriHealth Caritas. These parent companies represent 115 Medicaid MCOs in 37 states and cover nearly 30 million people[AR1] , roughly 36% of the total number of Medicaid lives. Some additional findings and statistics from the OIG’s Medicaid report included:

  • MCOs denied one out of eight (12.5%) requests for prior authorization (PA) in 2019.
  • MCOs fully or partially denied approximately 2.2 million PA requests in 2019.
  • 12 MCOs had PA denial rates greater than 25%—twice the overall rate.
  • Most State Medicaid agencies reported that they did not routinely review the appropriateness of a sample of MCO denials of PA requests.
  • Many states did not collect and monitor data on these decisions.
  • Absence of oversight of MCO decisions on PA requests presents a limitation that can allow inappropriate denials to go undetected in Medicaid managed care.
  • Most State Medicaid agencies reported they do not have a mechanism for patients or providers to submit a PA denial to an external medical reviewer independent of the MCO.
  • Although all State Medicaid agencies are required to offer State fair hearings as an appeal option, these administrative hearings may be difficult to navigate and burdensome on Medicaid patients. The OIG reported that Medicaid enrollees appealed only a small portion of PA denials to either their MCOs or to State fair hearings.
  • Seven of Molina’s 12 MCOs had PA denial rates greater than 25%.

As many of you are aware, VGM has participated in several meetings and discussions with CMS over the past 12 months around the topics of improper denials of PA and claims within managed Medicare and managed Medicaid, general lack of oversight for these plans, and overall network adequacy. We will continue to use findings like the ones outlined above along with other examples provided by our members to continue our discussions with CMS representatives, with the goal being to reduce or eliminate these issues within managed care in the future. Please continue to provide us with those examples of improper denials and access-to-care issues resulting from inadequate provider networks.

From Our Experts

Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse thumbnail Federal Actions This Week Signal The Administration Is Doubling Down On Its Goal To Eliminate Fraud Waste And Abuse This week, the Trump administration, through the Centers for Medicare & Medicaid Services (CMS), announced a significant deferral of federal Medicaid matching funds to Minnesota alongside the release of a new Request for Information (RFI) tied to the administration's Comprehensive Regulations to Uncover Suspicious Healthcare (CRUSH) initiative. These actions along with the changes to DMEPOS accreditation and enrollment signal the administration's aggressive posture on Medicaid and Medicare... VGM Response To CMS Moratorium On New DMEPOS Provider thumbnail VGM Response To CMS Moratorium On New DMEPOS Provider The federal moratorium on new DME suppliers presents a defining moment for us as an industry—an opportunity to demonstrate that the VGM members serving patients are the gold standard. We have long shown that our members operate with integrity, excellence in compliance, and unmatched commitment to service, efficiency, and patient outcomes. Now, we must elevate that message. Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium thumbnail Trump Administration Announces Nationwide DMEPOS Enrollment Moratorium In a press release published on the CMS website Feb. 25, 2026, it was announced that CMS will implement a six-month moratorium on new enrollments for DMEPOS suppliers. Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases thumbnail Proposed LCD Changes to Impact Seat Elevation on Group 2 Non-Complex Power Wheelchair Bases The DME Medicare Administrative Contractors (MACs) issued a proposed Local Coverage Determination (LCD) change for seat elevation use on group 2 non-complex power wheelchair bases (K0830, K0831 and K0108 on group 2 non-complex HD bases). John Quinlan Named 2026 Van G. Miller Homecare Champion thumbnail John Quinlan Named 2026 Van G. Miller Homecare Champion AAHomecare announced earlier this week that John Quinlan of Quinlan's Pharmacy in New York has been selected as the recipient of this year's Van G. Miller Award. John has been a valued VGM member for many years, and his leadership within the DMEPOS community has made a meaningful impact on patients, providers, and the industry as a whole. His commitment to quality care, patient access, and industry advocacy consistently sets him apart. Legislative Update On DMEPOS Bills – Letter To CMS Admin Dr. Oz To Delay Competitive Bidding Program thumbnail Legislative Update On DMEPOS Bills – Letter To CMS Admin Dr. Oz To Delay Competitive Bidding Program Many of you have already contacted your legislators in support of key DME legislation, including the DMEPOS Relief Act, the Choices for Increased Mobility Act, and the Supplemental Oxygen Access Reform (SOAR) Act. We now have another important issue to bring to your attention. CMS Revises Nebulizer Policy and ABN Form thumbnail CMS Revises Nebulizer Policy and ABN Form CMS has issued an update regarding revisions to the CMS Nebulizer Policy Article and guidance on the Advanced Beneficiary Notice of Noncoverage (ABN) Form. For dates of service on or after Feb. 1, 2026, suppliers must include the KX, GA, or GZ modifier to claims for the following nebulizer items: CMS Releases Updated Telehealth FAQ After Funding Bill Extends Flexibilities Through 2027 thumbnail CMS Releases Updated Telehealth FAQ After Funding Bill Extends Flexibilities Through 2027 Earlier this week, Congress extended Medicare telehealth flexibilities through Dec, 31, 2027, as part of the newly signed federal funding bill. In response, CMS has released updated Telehealth Frequently Asked Questions (FAQ) to provide clarity on what the extension means for both patients and providers.